Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Dextromethorphan + chlorpheniramine maleate + guaifenesin** is a fixed-dose, multi-ingredient over-the-counter (OTC) medication used primarily for temporary relief of symptoms associated with the common cold, including cough, congestion, runny nose, sneezing, itchy nose, and itchy or watery eyes[1][5]. The mechanism of action is multifactorial: - **Dextromethorphan** is a centrally acting cough suppressant that reduces the urge to cough by acting on the brain’s cough center[1][5]. - **Chlorpheniramine maleate** is a first-generation antihistamine that blocks histamine receptors, thus alleviating allergy symptoms such as runny nose, sneezing, itchy nose, and watery eyes[1][5]. - **Guaifenesin** is an expectorant that increases hydration of respiratory tract secretions, thinning mucus and making it easier to clear from the airways[1][5]. This combination is intended for both adults and children, though age restrictions and dosing should follow product labeling and medical advice. Common side effects include drowsiness, dizziness, dry mouth, nausea, and headache[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on dextromethorphan + chlorpheniramine maleate + guaifenesin.